Annual Current Liabilities
$26.39 B
-$2.27 B-7.91%
31 December 2023
Summary:
Novartis AG annual total current liabilities is currently $26.39 billion, with the most recent change of -$2.27 billion (-7.91%) on 31 December 2023. During the last 3 years, it has fallen by -$6.67 billion (-20.17%). NVS annual current liabilities is now -20.17% below its all-time high of $33.06 billion, reached on 31 December 2020.NVS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$28.13 B
+$520.00 M+1.88%
30 September 2024
Summary:
Novartis AG quarterly total current liabilities is currently $28.13 billion, with the most recent change of +$520.00 million (+1.88%) on 30 September 2024. Over the past year, it has dropped by -$20.26 billion (-41.87%). NVS quarterly current liabilities is now -49.88% below its all-time high of $56.13 billion, reached on 31 March 2019.NVS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.9% | -41.9% |
| 3 y3 years | -20.2% | -5.8% |
| 5 y5 years | -10.9% | -0.3% |
NVS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.2% | at low | -41.9% | +6.6% |
| 5 y | 5 years | -20.2% | at low | -41.9% | +6.6% |
| alltime | all time | -20.2% | +265.9% | -49.9% | +290.1% |
Novartis AG Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.13 B(+1.9%) |
| June 2024 | - | $27.61 B(-5.7%) |
| Mar 2024 | - | $29.29 B(+11.0%) |
| Dec 2023 | $26.39 B(-7.9%) | $26.39 B(-45.5%) |
| Sept 2023 | - | $48.39 B(+51.7%) |
| June 2023 | - | $31.91 B(+4.5%) |
| Mar 2023 | - | $30.55 B(+6.6%) |
| Dec 2022 | $28.66 B(-5.1%) | $28.66 B(+1.8%) |
| Sept 2022 | - | $28.16 B(+1.9%) |
| June 2022 | - | $27.65 B(-7.2%) |
| Mar 2022 | - | $29.81 B(-1.3%) |
| Dec 2021 | $30.21 B(-8.6%) | $30.21 B(+1.1%) |
| Sept 2021 | - | $29.88 B(+0.8%) |
| June 2021 | - | $29.63 B(-1.7%) |
| Mar 2021 | - | $30.16 B(-8.8%) |
| Dec 2020 | $33.06 B(+17.0%) | $33.06 B(+3.8%) |
| Sept 2020 | - | $31.84 B(+8.4%) |
| June 2020 | - | $29.38 B(-6.1%) |
| Mar 2020 | - | $31.29 B(+10.7%) |
| Dec 2019 | $28.26 B(-4.5%) | $28.26 B(+0.2%) |
| Sept 2019 | - | $28.22 B(-6.3%) |
| June 2019 | - | $30.11 B(-46.4%) |
| Mar 2019 | - | $56.13 B(+89.6%) |
| Dec 2018 | $29.61 B(+26.5%) | $29.61 B(+4.5%) |
| Sept 2018 | - | $28.33 B(+1.4%) |
| June 2018 | - | $27.94 B(-1.0%) |
| Mar 2018 | - | $28.22 B(+20.6%) |
| Dec 2017 | $23.40 B(+5.4%) | $23.40 B(-7.8%) |
| Sept 2017 | - | $25.38 B(-2.9%) |
| June 2017 | - | $26.15 B(-0.7%) |
| Mar 2017 | - | $26.33 B(+18.6%) |
| Dec 2016 | $22.21 B(-6.3%) | $22.21 B(-9.7%) |
| Sept 2016 | - | $24.60 B(-6.3%) |
| June 2016 | - | $26.27 B(-5.6%) |
| Mar 2016 | - | $27.82 B(+17.3%) |
| Dec 2015 | $23.71 B(-12.1%) | $23.71 B(-15.8%) |
| Sept 2015 | - | $28.16 B(-4.2%) |
| June 2015 | - | $29.39 B(+1.2%) |
| Mar 2015 | - | $29.05 B(+7.7%) |
| Dec 2014 | $26.97 B(+2.3%) | $26.97 B(+1.3%) |
| Sept 2014 | - | $26.62 B(-3.4%) |
| June 2014 | - | $27.56 B(+11.3%) |
| Mar 2014 | - | $24.76 B(-6.1%) |
| Dec 2013 | $26.37 B(+9.6%) | $26.37 B(+2.2%) |
| Sept 2013 | - | $25.81 B(+5.8%) |
| June 2013 | - | $24.39 B(-7.5%) |
| Mar 2013 | - | $26.37 B(+9.6%) |
| Dec 2012 | $24.05 B | $24.05 B(+10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $21.86 B(-12.3%) |
| June 2012 | - | $24.92 B(-8.9%) |
| Mar 2012 | - | $27.36 B(+18.2%) |
| Dec 2011 | $23.15 B(-6.1%) | $23.15 B(-10.4%) |
| Sept 2011 | - | $25.83 B(-12.5%) |
| June 2011 | - | $29.54 B(-8.3%) |
| Mar 2011 | - | $32.22 B(+30.7%) |
| Dec 2010 | $24.66 B(+26.6%) | $24.66 B(-10.8%) |
| Sept 2010 | - | $27.66 B(+55.1%) |
| June 2010 | - | $17.83 B(+2.3%) |
| Mar 2010 | - | $17.43 B(-10.5%) |
| Dec 2009 | $19.47 B(+18.0%) | $19.47 B(+8.8%) |
| Sept 2009 | - | $17.90 B(+16.6%) |
| June 2009 | - | $15.36 B(+2.5%) |
| Mar 2009 | - | $14.99 B(-9.2%) |
| Dec 2008 | $16.50 B(-0.8%) | $16.50 B(-17.3%) |
| Sept 2008 | - | $19.95 B(+1.4%) |
| June 2008 | - | $19.68 B(+15.4%) |
| Mar 2008 | - | $17.06 B(+2.5%) |
| Dec 2007 | $16.64 B(+2.5%) | $16.64 B(-4.9%) |
| Sept 2007 | - | $17.50 B(+9.5%) |
| June 2007 | - | $15.98 B(-8.9%) |
| Mar 2007 | - | $17.55 B(+8.1%) |
| Dec 2006 | $16.23 B(+5.9%) | $16.23 B(-0.5%) |
| Sept 2006 | - | $16.32 B(-2.6%) |
| June 2006 | - | $16.76 B(+7.5%) |
| Mar 2006 | - | $15.59 B(+1.7%) |
| Dec 2005 | $15.33 B(+29.4%) | $15.33 B(+23.0%) |
| Sept 2005 | - | $12.46 B(-1.5%) |
| June 2005 | - | $12.64 B(+11.7%) |
| Mar 2005 | - | $11.32 B(-4.4%) |
| Dec 2004 | $11.85 B(+27.1%) | $11.85 B(+31.9%) |
| Sept 2004 | - | $8.98 B(-0.1%) |
| June 2004 | - | $8.99 B(-4.6%) |
| Mar 2004 | - | $9.42 B(+1.1%) |
| Dec 2003 | $9.32 B(+12.7%) | $9.32 B(+11.7%) |
| Sept 2003 | - | $8.35 B(-15.0%) |
| June 2003 | - | $9.82 B(+2.9%) |
| Mar 2003 | - | $9.54 B(+15.3%) |
| Dec 2002 | $8.27 B(-3.7%) | $8.27 B(-0.1%) |
| Sept 2002 | - | $8.28 B(+2.0%) |
| June 2002 | - | $8.12 B(-5.5%) |
| Dec 2001 | $8.59 B(+19.1%) | $8.59 B(+5.6%) |
| June 2001 | - | $8.13 B(+12.7%) |
| Dec 2000 | $7.21 B(-34.0%) | $7.21 B(-19.3%) |
| June 2000 | - | $8.94 B |
| Dec 1999 | $10.93 B(+0.4%) | - |
| Dec 1998 | $10.89 B | - |
FAQ
- What is Novartis AG annual total current liabilities?
- What is the all time high annual current liabilities for Novartis AG?
- What is Novartis AG annual current liabilities year-on-year change?
- What is Novartis AG quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Novartis AG?
- What is Novartis AG quarterly current liabilities year-on-year change?
What is Novartis AG annual total current liabilities?
The current annual current liabilities of NVS is $26.39 B
What is the all time high annual current liabilities for Novartis AG?
Novartis AG all-time high annual total current liabilities is $33.06 B
What is Novartis AG annual current liabilities year-on-year change?
Over the past year, NVS annual total current liabilities has changed by -$2.27 B (-7.91%)
What is Novartis AG quarterly total current liabilities?
The current quarterly current liabilities of NVS is $28.13 B
What is the all time high quarterly current liabilities for Novartis AG?
Novartis AG all-time high quarterly total current liabilities is $56.13 B
What is Novartis AG quarterly current liabilities year-on-year change?
Over the past year, NVS quarterly total current liabilities has changed by -$20.26 B (-41.87%)